Drawing for I-TRACKER

USPTO serial 79289073

I-TRACKER

Reviewed by CopyMark Law Group

Reg. 6358437Status 700Renewal
Filing date
Status date
Registration date
May 25, 2021
Examiner
HUDSON, TAMARA BREE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with I-TRACKER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $797*

Plus Government fees of $975

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Cecilia R. Dickson

Cecilia R. Dickson The Webb Law Firm420 Fort Duquesne Boulevard, Suite 1200One Gateway CenterPittsburgh, PA 15222

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic preparations for scientific use; diagnostic preparations for scientific use or for research; chemical preparations for use in scientific diagnosis; laboratory chemical preparations for scientific use; diagnostic preparations for scientific use; products for diagnosis for scientific use, namely, diagnostic reagents and assays; products for diagnosis intended for scientific use, namely, diagnostic reagents and assays; diagnostic reagents for scientific use; diagnostic reagents for in-vitro use for biochemistry, clinical chemistry and microbiology; diagnostic reagents for scientific use or for research; laboratory reagents for scientific use; universal reagents for automated laboratory testing systems; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; chemical substances for laboratory use, other than for medical or veterinary purposes; chemicals for use in industry and scienceACTIVE—
005Biotechnological preparations for medical use, namely, reagent and assays for in vitro diagnostic; chemical preparations for medical use for blood analysis; diagnostic preparations for medical use; diagnostic preparations for medical or veterinary use; in-vitro diagnostic preparations for medical use; diagnostic kits consisting of medical diagnostic reagents and assays for testing bodily fluid; analytical reagents for medical use; chemical reagents for medical use; chemical reagents for medical diagnosis; diagnostic biomarking reagents for medical use; diagnostic reagents for medical use; clinical diagnostic reagents; reagents and substances for medical and veterinary diagnostic purposes; immunological reagents for medical use; reagents for analysis for medical use; reagents for medical diagnosis; reagents for diagnostic tests for medical use; reagents for in vitro use in laboratories for medical use; diagnostic substances for medical use; medical diagnostic reagents and assays for testing bodily fluids; diagnostic reagents for medical use sold as kitsACTIVE—
010Medical diagnostic instruments in the nature of automated analyzers for body fluids for medical use; measuring apparatus for medical diagnostic use, namely, devices for measuring blood proteins, antibodies, enzymes, immunoglobulins, hormones and drugs; medical diagnostic apparatus for medical use, namely, blood testing apparatus, immunochemical testing apparatus; medical diagnostic testing apparatus for immunoassay procedures; blood testing apparatus for medical use; diagnostic apparatus for medical use, namely, medical diagnostic apparatus for the analysis of body fluids; testing apparatus for medical use, namely, blood testing apparatus, immunochemical testing apparatus; apparatus for analysis of substances for medical use, namely, apparatus for blood analysis for medical purposes; apparatus for conducting diagnostic tests for medical use, namely, medical diagnostic apparatus for the analysis of body fluids and for detecting antibodies; diagnostic apparatus for medical use, namely, medical diagnostic apparatus for the analysis of body fluids; diagnostic, testing and monitoring equipment, namely, medical diagnostic apparatus for analysis of body fluids and detecting and monitoring antibodies; medical diagnostic instruments for the analysis of body fluids; testing instruments for use in medical diagnosis, namely, blood testing apparatus, immunochemical testing apparatus; electrical instruments for medical use for blood diagnosis; medical diagnostic-test instruments for immunoassay proceduresACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 25, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
May 7, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 27, 2025CHLDCHANGE OF OWNER RECEIVED FROM IB—
Jan 31, 2025ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Oct 11, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 16, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 31, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 11, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 17, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 17, 2021FIMPFINAL DISPOSITION PROCESSED—
Aug 25, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 25, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 15, 2021GPNXNOTIFICATION PROCESSED BY IB—
Mar 9, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 9, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 24, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 24, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 17, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 3, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 3, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Feb 3, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 3, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 3, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 28, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 28, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 28, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 18, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 17, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 17, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 17, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Dec 17, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 17, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 17, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 5, 2020RFNTREFUSAL PROCESSED BY IB—
Aug 20, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 20, 2020RFRRREFUSAL PROCESSED BY MPU—
Jul 15, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 14, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 14, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 10, 2020DOCKASSIGNED TO EXAMINER—
Jul 10, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 9, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance